Key result
Discharge with ≥5 long-term medicines links to ~27% lower mortality but more readmissions and adverse reactions.
Why the study?
The study was conducted to quantify the prevalence and incidence of medicines use per patient hospital admission and to illustrate the importance of definitions in quantifying medicines use.
Observational (n=39,703)
Yes
Odds Ratio: 0.73 (95% CI 0.67–0.79)
Polypharmacy at discharge is highly prevalent and associated with increased risks of readmission and adverse drug reactions, highlighting the need for standardized definitions to quantify medicines use.
Polypharmacy at discharge was associated with mixed post-discharge risks; leaves open whether deprescribing improves net outcomes in observational cohorts.
Aim Quantify the prevalence and incidence of medicines use per patient hospital admission and illustrate the importance of definitions in quantifying medicines use. Method Data from all public hospitals in Canterbury, New Zealand, between 01/07/2022 and 01/07/2023 were extracted, totalling 53 580 hospital admissions of 39 703 adult patients who survived to discharge. Patients' medicines use from hospital admission to discharge was quantified and linked to outcomes data. Results The average number of medicines at discharge was 3.7 (standard deviation [SD] 3.4) long term, 1.2 (SD 1.2) short course and 4.3 (SD 2.4) as needed. The prevalence of polypharmacy at discharge was 36% (19 511/53 580) for long‐term medicines and 84% (45 214/53 580) for all medicines. Per admission, an average of 1.0 (SD 1.9) long‐term medicines were started, 0.5 (SD 1.1) were stopped and 0.3 (SD 0.7) had dose changes. Per admission, there were 11.5 (SD 6.0) different medicines prescribed, 14.4 (SD 9.9) prescriptions and 26 (IQR 11 to 60) doses of medicines administered. For patients with five or more long‐term medicines at discharge, the adjusted odds of mortality were decreased (adjusted odds ratio [aOR] 0.73, 95% CI 0.67 to 0.79), and the adjusted odds of hospital readmission or mortality and adverse drug reaction occurrence were increased (aOR 1.09, 95% CI 1.03 to 1.15, and aOR 1.33, 95% CI 1.23 to 1.44). Conclusion Standard definitions are needed to validly quantify medicines use and compare use between health care settings. Where longitudinal data exist, changes in medicines use can be measured, rather than inferred from cross‐sectional studies.
No takes yet. Share an insight, caveat, or question.
Pairman et al. (2026) conducted an observational in Hospital admission (n=39,703). Five or more long-term medicines at discharge vs. Fewer than five long-term medicines was evaluated on Mortality (aOR 0.73, 95% CI 0.67 to 0.79). Discharge with five or more long-term medicines was associated with decreased odds of mortality (aOR 0.73; 95% CI 0.67-0.79) but increased odds of readmission or mortality and adverse drug reactions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: